Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence

Vulvar and vaginal cancers are relatively rare cancers, but their incidence is increasing worldwide. Overall, 78% of vaginal cancers and 25% of vulvar cancers are associated with Human papillomavirus (HPV) infection. Immunization could be an option for the management of these cases. We researched an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bechini, Angela, Moscadelli, Andrea, Velpini, Beatrice, Bonito, Benedetta, Orlando, Paolo, Putignano, Pasqua, Posi, Silvano, Stacchini, Lorenzo, Bonanni, Paolo, Boccalini, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302061/
https://www.ncbi.nlm.nih.gov/pubmed/37376473
http://dx.doi.org/10.3390/vaccines11061084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302061/
https://www.ncbi.nlm.nih.gov/pubmed/37376473
http://dx.doi.org/10.3390/vaccines11061084

Ejemplares similares